Tenax Therapeutics Inc (TENX)
3.55
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.66
+0.11
(+3.10%)
After-Hours: 20:00
Tenax Therapeutics Cash and Short Term Investments (Quarterly): 9.792M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.792M |
| September 30, 2023 | 11.14M |
| June 30, 2023 | 13.39M |
| March 31, 2023 | 14.41M |
| December 31, 2022 | 2.124M |
| September 30, 2022 | 3.806M |
| June 30, 2022 | 7.229M |
| March 31, 2022 | 2.869M |
| December 31, 2021 | 5.584M |
| September 30, 2021 | 8.354M |
| June 30, 2021 | 2.182M |
| March 31, 2021 | 4.032M |
| December 31, 2020 | 6.713M |
| September 30, 2020 | 8.708M |
| June 30, 2020 | 4.554M |
| March 31, 2020 | 4.857M |
| December 31, 2019 | 5.400M |
| September 30, 2019 | 7.128M |
| June 30, 2019 | 8.909M |
| March 31, 2019 | 10.82M |
| December 31, 2018 | 12.86M |
| September 30, 2018 | 4.856M |
| June 30, 2018 | 6.407M |
| March 31, 2018 | 6.618M |
| December 31, 2017 | 7.727M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.535M |
| June 30, 2017 | 8.796M |
| March 31, 2017 | 12.52M |
| December 31, 2016 | 13.28M |
| September 30, 2016 | 7.478M |
| June 30, 2016 | 9.952M |
| March 31, 2016 | 15.77M |
| October 31, 2015 | 21.68M |
| July 31, 2015 | 21.31M |
| April 30, 2015 | 17.13M |
| January 31, 2015 | 17.07M |
| October 31, 2014 | 22.58M |
| July 31, 2014 | 26.12M |
| April 30, 2014 | 58.32M |
| January 31, 2014 | 6.340M |
| October 31, 2013 | 2.543M |
| July 31, 2013 | 4.073M |
| April 30, 2013 | 0.7835M |
| January 31, 2013 | 0.8288M |
| October 31, 2012 | 1.512M |
| July 31, 2012 | 2.691M |
| April 30, 2012 | 1.880M |
| January 31, 2012 | 3.282M |
| October 31, 2011 | 2.004M |
| July 31, 2011 | 3.998M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.124M
Minimum
Dec 2022
14.41M
Maximum
Mar 2023
6.905M
Average
6.713M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| CEL-SCI Corp | 3.241M |
| AIM ImmunoTech Inc | 13.07M |
| IGC Pharma Inc | 1.378M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Protalix BioTherapeutics Inc | 48.49M |